Requirement for Ras/Rac1-Mediated p38 and c-Jun N-Terminal Kinase Signaling in Stat3 Transcriptional Activity Induced by the Src Oncoprotein

REFERENCES

• Aftab, D. T., J. Kwan, and J. Martin 1997. Ras-independent transformation by v-Src. Proc. Natl. Acad. Sci. USA 94:3028–3033.
   PubMedGoogle Scholar
• Alessandrini, A., H. Greulich, W. Huang, and J. Erikson 1996. Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells. J. Biol. Chem. 271:31612–31618.
   PubMedGoogle Scholar
• Beadling, C., J. Ng, J. W. Babbage, and J. Cantrell 1996. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf-1/ERK2 MAP kinase pathway. EMBO J. 15:1902–1913.
   PubMedGoogle Scholar
• Besser, D., J. F. Bromberg, J. E. Darnell Jr., and J. Hanafusa 1999. A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Mol. Cell. Biol. 19:1401–1409.
   PubMedGoogle Scholar
• Boulton, T. G., Z. Zhong, Z. Wen, J. E. Darnell Jr., N. Stahl, and J. Yancopoulos 1995. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring H7-sensitive kinase. Proc. Natl. Acad. Sci. USA 92:6915–6919.
   PubMed Web of Science ®Google Scholar
• Bromberg, J. F., C. M. Horvath, D. Besser, W. W. Lathem, J. E. Darnell Jr.. 1998. Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18:2553–2558.
   PubMed Web of Science ®Google Scholar
• Bromberg, J. F., C. M. Horvath, Z. Wen, R. D. Schreiber, J. E. Darnell Jr.. 1996. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc. Natl. Acad. Sci. USA 93:7673–7678.
   PubMed Web of Science ®Google Scholar
• Caldenhoven, E., T. B. van Dijk, R. Solari, J. Armstrong, J. A. M. Raaijmakers, J. W. J. Lammers, L. Koenderman, and J. de Groot 1996. STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J. Biol. Chem. 271:13221–13227.
   PubMed Web of Science ®Google Scholar
• Cao, X., X. Tay, G. R. Guy, and J. Tan 1996. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol. Cell. Biol. 16:1595–1603.
   PubMed Web of Science ®Google Scholar
• Catlett-Falcone, R., T. H. Landowski, M. M. Oshiro, J. Turkson, A. Levitzki, R. Savino, G. Ciliberto, L. Moscinski, J. L. Fernandez-Luna, G. Nunez, W. S. Dalton, and J. Jove 1999. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10:105–115.
   PubMed Web of Science ®Google Scholar
• Ceresa, B. P., C. M. Horvath, and J. Pessin 1997. Signal transducer and activator of transcription-3 serine phosphorylation by insulin is mediated by a Ras/Raf/MEK-dependent pathway. Endocrinology 138:4131–4137.
   PubMedGoogle Scholar
• Chai, S. K., G. L. Nichols, and J. Rothman 1997. Constitutive activation of JAKs and STATs in BCL-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. J. Immunol. 159:4720–4728.
   PubMed Web of Science ®Google Scholar
• Chaturvedi, P., S. Sharma, and J. Reddy 1997. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs. Mol. Cell. Biol. 17:3295–3304.
   PubMed Web of Science ®Google Scholar
• Chung, J., E. Uchida, T. C. Grammer, and J. Blenis 1997. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 17:6508–6515.
   PubMed Web of Science ®Google Scholar
• Cressman, D. E., L. E. Greenbaum, R. A. DeAngelis, G. Ciliberto, E. E. Furth, V. Poli, and J. Taub 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274:1379–1383.
   PubMed Web of Science ®Google Scholar
• Danial, N. N., A. Pernis, and J. Rothman 1995. Jak-STAT signaling induced by the v-abl oncogene. Science 269:1875–1877.
   PubMed Web of Science ®Google Scholar
• Darnell, J. E. Jr.. 1997. STATs and gene regulation. Science 277:1630–1635.
   PubMed Web of Science ®Google Scholar
• Darnell, J. E. Jr., I. M. Kerr, and J. Stark 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415–1421.
   PubMed Web of Science ®Google Scholar
• David, M., E. Petricoin III, C. Benjamin, R. Pine, M. J. Weber, and J. Larner 1995. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science 269:1721–1723.
   PubMed Web of Science ®Google Scholar
• del Peso, L., M. Gonzalez-Garcia, C. Page, R. Herrera, and J. Nunez 1997. Interleukin 3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687–689.
   PubMed Web of Science ®Google Scholar
• Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and J. Saltiel 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686–7689.
   PubMed Web of Science ®Google Scholar
• Enslen, H., J. Raingeaud, and J. Davis 1998. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273:1741–1748.
   PubMed Web of Science ®Google Scholar
• Fan, G., S. E. Merritt, M. Kortenjann, P. E. Shaw, and J. Holzman 1996. Dual leucine zipper-bearing kinase (DLK) activates p46sapk and p38mapk but not ERK2. J. Biol. Chem. 271:24788–24793.
   PubMed Web of Science ®Google Scholar
• Fanger, G. R., P. Gerwins, C. Widmann, M. B. Jarpe, and J. Johnson 1997. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr. Opin. Genet. Dev. 7:67–74.
   PubMed Web of Science ®Google Scholar
• Frank, D. A., S. Mahajan, and J. Ritz 1997. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. J. Clin. Investig. 100:3140–3148.
   PubMed Web of Science ®Google Scholar
• Fukada, T., M. Hibi, Y. Yamanaka, M. Takahashi-Tezuka, Y. Fujitani, T. Yamaguchi, K. Nakajima, and J. Hirano 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 5:449–460.
   PubMed Web of Science ®Google Scholar
• Fukui, Y., A. R. Saltiel, and J. Hanafusa 1991. Phosphatidylinositol-3 kinase is activated in v-src, v-yes, and v-fps transformed chicken embryo fibroblasts. Oncogene 6:407–411.
   PubMedGoogle Scholar
• Garcia, R., and J. Jove 1998. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J. Biomed. Sci. 5:79–85.
   PubMed Web of Science ®Google Scholar
• Garcia, R., C.-L. Yu, A. Hudnall, R. Catlett, K. L. Nelson, T. Smithgall, D. J. Fujita, S. P. Ethier, and J. Jove 1997. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ. 8:1267–1276.
   PubMedGoogle Scholar
• Gollob, J. A., C. P. Schnipper, E. A. Murphy, J. Ritz, and J. Frank 1999. The functional synergy between IL-12 and IL-2 involves p38 MAP kinase and is associated with the augmentation of STAT serine phosphorylation. J. Immunol. 162:4472–4481.
   PubMed Web of Science ®Google Scholar
• Grandis, J. R., S. D. Drenning, A. Chakraborty, M.-Y. Zhou, Q. Zeng, A. S. Pitt, and J. Tweardy 1998. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J. Clin. Investig. 102:1385–1392.
   PubMed Web of Science ®Google Scholar
• Greulich, H., C. Reichman, and J. Hanafusa 1996. Delay in serum stimulation of Erk activity caused by oncogenic transformation. Oncogene 12:1689–1695.
   PubMedGoogle Scholar
• Hauser, P. J., D. Agrawal, J. Hackney, and J. Pledger 1998. STAT3 activation accompanies keratinocyte differentiation. Cell Growth Differ. 10:847–855.
   Google Scholar
• Her, J.-H., S. Lakhani, K. Zu, J. Vila, P. Dent, T. W. Sturgill, and J. Weber 1993. Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation. Biochem. J. 296:25–31.
   PubMedGoogle Scholar
• Hill, C. S., and J. Treisman 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199–211.
   PubMed Web of Science ®Google Scholar
• Hill, C. S., and J. Treisman 1995. Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J. 14:5037–5047.
   PubMed Web of Science ®Google Scholar
• Hill, C. S., J. Wynne, and J. Treisman 1995. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81:1159–1170.
   PubMed Web of Science ®Google Scholar
• Holland, P. M., M. Suzanne, J. S. Campbell, S. Noselli, and J. Cooper 1997. MKK7 is a stress-activated mitogen-activated protein kinase kinase functionally related to hemipterous. J. Biol. Chem. 272:24994–24998.
   PubMed Web of Science ®Google Scholar
• Holzman, L. Unpublished results.
   Google Scholar
• Jain, N., T. Zhang, S. L. Fong, C. P. Lim, and J. Cao 1998. Repression of Stat3 activity by mitogen-activated protein kinase (MAPK). Oncogene 17:3157–3167.
   PubMed Web of Science ®Google Scholar
• Johnson, P. J., P. M. Coussens, A. V. Danko, and J. Shalloway 1985. Overexpressed pp60c-src can induce focus formation without complete transformation of NIH 3T3 cells. Mol. Cell. Biol. 5:1073–1083.
   PubMedGoogle Scholar
• Khosravi-Far, R., P. A. Solski, G. J. Clark, M. S. Kinch, and J. Der 1995. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell. Biol. 15:6443–6453.
   PubMed Web of Science ®Google Scholar
• Li, J., and J. Smithgall 1998. Fibroblasts transformation by Fps/Fes tyrosine kinases requires Ras, Rac, and Cdc42 and induces extracellular signal-regulated and c-Jun N-terminal kinase activation. J. Biol. Chem. 273:13828–13834.
   PubMedGoogle Scholar
• Lim, L., E. Manser, T. Leung, and J. Hall 1996. Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signaling pathways. Eur. J. Biochem. 242:171–185.
   PubMedGoogle Scholar
• Liu, A. X., J. R. Testa, T. C. Hamilton, R. Jove, S. V. Nicosia, and J. Cheng 1998. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells. Cancer Res. 58:2973–2977.
   PubMed Web of Science ®Google Scholar
• Lund, T. C., R. Garcia, M. M. Medveczky, R. Jove, and J. Medveczky 1997. Activation of STAT transcription factors by herpesvirus saimiri Tip-484 requires p56lck. J. Virol. 71:6677–6682.
   PubMedGoogle Scholar
• Migone, T. S., J. X. Lin, A. Cereseto, J. C. Mulloy, J. J. O’Shea, G. Franchini, and J. Leonard 1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269:79–81.
   PubMed Web of Science ®Google Scholar
• Minden, A., A. Lin, F.-X. Claret, A. Abo, and J. Karin 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPase Rac and Cdc42Hs. Cell 81:1147–1157.
   PubMed Web of Science ®Google Scholar
• Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R. J. Davis, G. L. Johnson, and J. Karin 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719–1723.
   PubMed Web of Science ®Google Scholar
• Moodie, S. A., B. M. Willumsen, M. J. Weber, and J. Wolfman 1993. Complexes of Ras-GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 260:1658–1661.
   PubMed Web of Science ®Google Scholar
• Morooka, T., and J. Nishida 1998. Requirement of p38 mitogen-activated protein kinase-activated protein kinase for neuronal differentiation in PC12 cells. J. Biol. Chem. 273:24285–24288.
   PubMed Web of Science ®Google Scholar
• Ng, J., and J. Cantrell 1997. STAT3 is a serine kinase target in T lymphocytes. J. Biol. Chem. 272:24542–24549.
   PubMedGoogle Scholar
• Pumiglia, K., Y.-H. Chow, J. Fabian, D. Morrison, S. Decker, and J. Jove 1995. Raf-1 N-terminal sequences necessary for Ras-Raf interaction and signal transduction. Mol. Cell. Biol. 15:398–406.
   PubMedGoogle Scholar
• Qureshi, S. A., K. Alexandropoulos, M. Rim, C. K. Joseph, J. T. Bruder, U. R. Rapp, and J. Foster 1992. Evidence that Ha-Ras mediates two distinguishable intracellular signals activated by v-Src. J. Biol. Chem. 267:17635–17639.
   PubMedGoogle Scholar
• Rodriguez-Viciana, P., P. H. Warne, A. Khwaja, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, and J. Downward 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457–467.
   PubMed Web of Science ®Google Scholar
• Schindler, C., J. E. Darnell Jr.. 1995. Transcriptional responses to polypeptide ligands: the Jak-STAT pathway. Annu. Rev. Biochem. 64:621–651.
   PubMed Web of Science ®Google Scholar
• Sengupta, T. K., E. S. Talbot, P. A. Scherle, and J. Ivashkiv 1998. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. Proc. Natl. Acad. Sci. USA 95:11107–11112.
   PubMed Web of Science ®Google Scholar
• Stacey, D. W., M. Roudebush, R. Day, S. D. Mosser, J. B. Gibbs, and J. Feig 1991. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes. Oncogene 6:2297–2304.
   PubMed Web of Science ®Google Scholar
• Stofega, M. R., C.-L. Yu, J. Wu, and J. Jove 1997. Activation of extracellular signal-regulated kinase (ERK) by mitogenic stimuli is repressed in v-Src transformed cells. Cell Growth Differ. 8:113–119.
   PubMedGoogle Scholar
• Symons, M. 1996. Rho family of GTPases: the cytoskeleton and beyond. Trends Biochem. Sci. 21:178–181.
   PubMed Web of Science ®Google Scholar
• Takeda, K., K. Noguchi, W. Shi, T. Tanaka, M. Matsumoto, N. Yoshida, T. Kishimoto, and J. Akira 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94:3801–3804.
   PubMed Web of Science ®Google Scholar
• Takemoto, S., J. C. Mulloy, A. Cereseto, T. S. Migone, B. K. Patel, M. Matsuoka, K. Yamaguchi, K. Takatsuki, S. Kamihira, J. D. White, W. J. Leonard, T. Waldmann, and J. Franchini 1997. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc. Natl. Acad. Sci. USA 94:13897–13902.
   PubMed Web of Science ®Google Scholar
• Tibbles, L. A., Y. L. Ing, F. Kiefer, J. Chan, N. Iscove, J. R. Woodgett, and J. Lassam 1996. MLK-3 activates the SAPK/JNK and p38 pathways via SEK1 and MKK3/6. EMBO J. 15:7026–7035.
   PubMed Web of Science ®Google Scholar
• Turkson, J., T. Bowman, R. Garcia, E. Caldenhoven, R. P. De Groot, and J. Jove 1998. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18:2545–2552.
   PubMed Web of Science ®Google Scholar
• Wagner, B. J., T. E. Hayes, C. J. Hoban, and J. Cochran 1990. The SIF binding elements confers sis/PDGF inducibility onto the c-fos promoter. EMBO J. 9:4477–4484.
   PubMed Web of Science ®Google Scholar
• Wang, Z., B. J. Canagarajah, J. C. Boehm, S. Kassisa, M. H. Cobb, P. R. Young, S. Abdel-Meguid, J. L. Adams, and J. Goldsmith 1998. Structural basis of inhibitor selectivity in MAP kinases. Structure 6:1117–1128.
   PubMed Web of Science ®Google Scholar
• Weber-Nordt, R. M., C. Egen, J. Wehinger, W. Ludwig, V. Gouilleux-Gruart, R. Mertelsmann, and J. Finke 1996. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88:809–816.
   PubMed Web of Science ®Google Scholar
• Wen, Z., J. E. Darnell Jr.. 1997. Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res. 25:2062–2067.
   PubMed Web of Science ®Google Scholar
• Wen, Z., Z. Zhong, J. E. Darnell Jr.. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241–250.
   PubMed Web of Science ®Google Scholar
• Whalen, A. M., S. C. Galasinski, P. S. Shapiro, T. S. Nahreini, and J. Ahn 1997. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol. Cell. Biol. 17:1947–1958.
   PubMed Web of Science ®Google Scholar
• Whitmarsh, A. J., J. Cavanagh, C. Tournier, J. Yasuda, and J. Davis 1998. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281:1671–1674.
   PubMed Web of Science ®Google Scholar
• Whitmarsh, A. J., S.-H. Yang, M. S.-S. Su, A. D. Sharrocks, and J. Davis 1997. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell. Biol. 17:2360–2371.
   PubMed Web of Science ®Google Scholar
• Wu, J., J. K. Harrison, P. Dent, K. R. Lynch, M. J. Weber, and J. Sturgill 1993. Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2. Mol. Cell. Biol. 13:4539–4548.
   PubMedGoogle Scholar
• Yamauchi, K., K. Holt, and J. Pessin 1993. Phosphatidylinositol 3-kinase functions upstream of Ras and Raf in mediating insulin stimulation of c-fos transcription. J. Biol. Chem. 268:14597–14600.
   PubMedGoogle Scholar
• Yano, H., S. Nakanishi, K. Kimura, N. Hanai, Y. Saitoh, Y. Fukui, Y. Nonomura, and J. Matsuda 1993. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:25846–25856.
   PubMed Web of Science ®Google Scholar
• Yao, Z., K. Diener, X. S. Wang, M. Zukowski, G. Matsumoto, G. Zhou, R. Mo, T. Sasaki, H. Nishina, C. C. Hui, T. H. Tan, J. P. Woodgett, and J. Penninger 1997. Activation of stress-activated protein kinases/c-Jun N-terminal protein kinases (SAPK/JNKs) by a novel mitogen-activated protein kinase kinase (MKK7). J. Biol. Chem. 272:32378–32383.
   PubMed Web of Science ®Google Scholar
• Yu, C.-L., D. J. Meyer, G. S. Campbell, A. C. Larner, C. Carter-Su, J. Schwartz, and J. Jove 1995. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269:81–83.
   PubMed Web of Science ®Google Scholar
• Zhang, Q., I. Nowak, E. C. Vonderheid, A. H. Rook, M. E. Kadin, P. C. Nowell, L. M. Shaw, and J. Wasik 1996. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc. Natl. Acad. Sci. USA 93:9148–9153.
   PubMed Web of Science ®Google Scholar
• Zhong, Z., Z. Wen, J. E. Darnell Jr.. 1994. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95–98.
   PubMed Web of Science ®Google Scholar